Literatur
- 01
Mouridsen H T, et al .
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
BIG 1-98 Collaborative Group.
N Engl J Med.
2009;
361 (8)
766-76
- 02
Goss P E, et al .
A randomised trial of letrozole in postmenopausal women after five years of tamoxifen
therapy for early-stage breast cancer.
N Engl J Med.
2003;
349
1793-1802
- 03
Howell A , Cuzick J , Baum M , et al .
ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination)
trial after completion of 5years' adjuvant treatment for breast cancer.
Lancet.
2005;
365
60-62
- 04
Rea D , et al .
Five Years of Exemestane as Initial Therapy Compared to 5 Years of Tamoxifen Followed
by Exemestane: The TEAM Trial, a Prospective, Randomized, Phase III Trial in Postmenopausal
Women with Hormone-Sensitive Early Breast Cancer.
Oral presentation SABCS.
2009;
Abstract #11
- 05
Coombes R C, Hall E , Gibson L J, et al .
A randomized trial of exemestane after two to three years of tamoxifen therapy in
postmenopausal women with primary breast cancer.
N Engl J Med.
2004;
350
1081-1092
- 06
Regan M M, et al .
Adjusting for Selective Crossover in Analyses of Letrozole (Let) Versus Tamoxifen
(Tam) in the BIG 1-98 Trial.
Oral presentation SABCS.
2009;
Abstract #16
- 07
Biss J M, et al .
Disease Related Outcome with Long Term Follow-Up: An Updated Analysis of the Intergroup
Exemestane Study (IES).
Oral presentation SABCS.
2009;
Abstract #12
- 08
Goss P E, et al .
Outcomes of Women Who Were Premenopausal at Diagnosis of Early Stage Breast Cancer
in the NCIC CTG MA 17 Trial.
Oral presentation SABCS.
;
Abstract #13
- 09
Robins J M, et al .
Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with
Inverse Probability of Censoring Weighted (IPCW) Log-Rank Tests.
Biometrics.
2000;
56 (3)
779-788
- 10
Rohan T E, et al .
A randomized controlled trial of calcium plus vitamin D supplementation and risk of
benign proliferative breast disease.
Breast Cancer Res Treat.
2009;
116 (2)
339-350
- 11
Heiss G , et al .
Colorectal Cancer in Women After Stopping Postmenopausal Hormone Therapy.
JAMA.
2008;
299 (9)
1036-1045
- 12
Manson J E, et al .
Estrogen therapy and coronary-artery calcification.
N Engl J Med.
2007;
356 (25)
2591-602
- 13
Jackson R D, et al .
Calcium plus Vitamin D Supplementation and the Risk of Fractures.
N Engl J Med.
2006;
354 (7)
669-683
- 14
Prentice R L, et al .
Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer.
JAMA.
2006;
295 (6)
629-642
Korrespondenz:
PD Dr. med. Michael Patrick Lux, MBA
Universitätsklinikum Erlangen
Qualitätsmanagementbeauftragter
Frauenklinik & Universitäts-Brustzentrum Franken
Universitätsstraße 21-23
91054 Erlangen
Email: michael.lux@uk-erlangen.de
